NeoCore Technology Co., Ltd.
4131
Rank in Stocks
#23998
NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture,... NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture, and distribution of biochips and advanced rapid nucleic acid hybridization devices. Their extensive product range features systems designed for food safety screening, human diagnostic arrays, agricultural analysis, and specific food examination arrays, in addition to a variety of laboratory instruments and DNA kits. The company further provides a suite of services, encompassing laboratory planning, design, and additional specialized support. Beyond its core biotech operations, NeoCore also participates in the wholesale and retail market for contact lenses. The firm, which was established in 1987 and is based in Tainan, Taiwan, underwent a name change in July 2023, transitioning from its former identity as DR. Chip Biotechnology Incorporation to its current name.
Share Price
$0.92672755
Last synced: 2026-11-10
Market Cap
$36.89M
Change (1 day)
-1.14%
Change (1 year)
-11.35%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade NeoCore Technology Co., Ltd. (4131)
Category
Healthcare
Operating Margin for NeoCore Technology Co., Ltd. (4131)
Operating Margin as of November 2026 TTM: -11.33%
According to NeoCore Technology Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -11.33%. At the end of 2025 the company had an operating margin of -25.66%.
Operating Margin history for NeoCore Technology Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -11.33% | -55.85% |
| 2025 | -25.66% | -79.18% |
| 2024 | -123.22% | -6.10% |
| 2023 | -131.23% | 220.62% |
| 2022 | -40.93% | 66.11% |
| 2021 | -24.64% | -14.09% |
| 2020 | -28.68% | 55.62% |
| 2019 | -18.43% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -103.41% |
US
|
|
| -149.01% | -86.85% |
US
|
|
| 25.57% | -102.26% |
AU
|
|
| 31.23% | -102.76% |
BE
|
|
| 29.35% | -102.59% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about NeoCore Technology Co., Ltd.'s operating margin
What is NeoCore Technology Co., Ltd.'s operating margin?
NeoCore Technology Co., Ltd.'s operating margin is -11.33%, as of Nov 2026.
What was NeoCore Technology Co., Ltd.'s operating margin in 2025?
In 2025, NeoCore Technology Co., Ltd.'s operating margin was -25.66%, compared with -123.22% in 2024.
How has NeoCore Technology Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, NeoCore Technology Co., Ltd.'s operating margin was highest in 2021 (-24.64%) and lowest in 2023 (-131.23%).
How does NeoCore Technology Co., Ltd.'s operating margin compare with similar companies?
NeoCore Technology Co., Ltd.'s operating margin (-11.33%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.